One of the major oncogenic pathways in breast cancer is PI3K/AKT/mTOR, which is frequently upregulated by activating mutations in PIK3CA, MAP3K1, and AKT1, or inactivating mutations in PTEN, leading to increased growth signaling. Here, MAP3K1 is linked to breast cancer.